House Republicans Take on Higher Education: Expanding the Inquiry Beyond Antisemitism (and Maybe a Few Study Breaks Too)

My Unexpected Encounter with Antisemitism in Universities Setting the Stage Republican Representative Virginia Foxx from North Carolina and head of the Education and Workforce Committee, recently made headlines with her decision to hold a hearing on antisemitism in universities. As a student myself, I never envisioned that such a topic would become a point of…

Read More

Lumen Welcomes Ashley Haynes Gaspar as Chief Revenue Officer: A Heartfelt and Insightful Addition to the Team

Seasoned leader Ashley Haynes-Gaspar appointed as Lumen’s Executive Vice President and Chief Revenue Officer Expanding role for customer-focused transformation In a strategic move to reinforce Lumen Technologies’ customer-focused transformation and drive growth, Ashley Haynes-Gaspar has been named as the Executive Vice President and Chief Revenue Officer. With her previous role as Executive Vice President –…

Read More

DYDX Founder Expresses Doubts About Bull Run Due to Low Participation

Founder of dYdX Expresses Skepticism Towards Crypto Bull Run Antonio Juliano Cautiously Optimistic about Recent Price Surge January 5: In a recent interview, Antonio Juliano, the founder of dYdX, a decentralized exchange (DEX), shared his doubts about the sustainability of the current crypto bull run. Despite the excitement surrounding the recent price surge, Juliano emphasized…

Read More

Renagade to Take the Stage at the 42nd Annual J.P. Morgan Healthcare Conference: A Must-See Presentation

Unlocking the Limitless Potential for RNA Medicines ReNAgade Therapeutics to Present at J.P. Morgan Healthcare Conference CAMBRIDGE, Mass.–(BUSINESS WIRE)–ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced that Amit D. Munshi, Chief Executive Officer, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 8:30…

Read More